Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 4:48pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
All 3 registration studies are adaptive Phase 2 studies that can seamlessly morph into and through the Phase2b/ Phase 3 / confirmatory study continuum by the very nature of the adaptive clinical trial
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 4:44pm
RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
3 registration studies that are already in progress - 1 in mBC (Bracelet-1) and 2 in mPDAC (Goblet-1).
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(96)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Sep 10, 2024 2:34pm
RE:RE:RE:RE:RE:How does Accelerated Approval work
brilliant... Accelerated Approval is possible with two randomised Phase IIs... but now we're going to run a third phase II.... That's interesting isn't it. ONCY will pay for it on
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 2:03pm
RE:RE:RE:RE:How does Accelerated Approval work
The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 1:43pm
RE:RE:RE:RE:How does Accelerated Approval work
According to the FDA’s Peter Marks, M.D., Ph.D. the FDA's Accelerated Approval provides small biotech's with a revenue stream to support on-going clinical development in "orphan"
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 1:30pm
RE:RE:RE:How does Accelerated Approval work
A primary endpoint for ONCY'S Phase 2 metastatic breast cancer (Bracelet-1) of overall survival (OS) has been maturing and the 2 year data timeline was reached at the end of May- early
...more
(91)
•••
venture009
X
View Profile
View Bullboard History
Post by
venture009
on Sep 10, 2024 12:04pm
Volume
After 2.5 hours of trading on Toronto only 100 share have traded. No one believes anything of significance is about to occur. The idea of an AA seems remote and a bit ridiculous. The company sends
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 11:40am
RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
September 10, 2024 - After much anticipation and concern, the BIOSECURE Act—which would prevent U.S. companies from working with certain Chinese biotech service providers—has passed a key threshold.
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 11:29am
RE:RE:RE:RE:AstraZeneca's ADC disappoints - on severe adverse events
https://stockhouse.com/companies/bullboard?symbol=oncy&postid=36216700
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 10, 2024 11:26am
RE:RE:RE:RE:“Second mouse gets the cheese “
AstraZeneca is now partnering with Roche to co-develop and commercialize a new biomarker is called normalized membrane ratio of TROP2 by quantitative continuous scoring (NMR-QCS). The TROP2
...more
(179)
•••
13X2413
X
View Profile
View Bullboard History
Comment by
13X2413
on Sep 09, 2024 9:15pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
Interesting way to spin a lot of frustrated bag holders as the stock drops to $1.28. Not far from a 12 month low. You think we should be positive about how things are going?
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 09, 2024 8:57pm
RE:RE:RE:ONCY's Bracelet-1 was in HR+/HER2 negative breast cancer
A primary endpoint for ONCY'S Phase 2 metastatic breast cancer (Bracelet-1) of overall survival (OS) has been maturing and the 2 year data timeline was reached at the end of May- early
...more
(5618)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Sep 09, 2024 8:53pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo
My oh my .. a lot of smack has suddenly appeared on this message board. Could it be that certain entities are feeling increasingly threatened ?
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Sep 09, 2024 8:14pm
TWO AND A HALF DECADES OF IMMUNE THERAPY
Coming Soon: 2 1/2 decades of cancer immunotherapy: Pela...the drug that changed absolutely nothing.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed